New opportunities for the use of “dry” carbon dioxide baths in the complex treatment of patients with chronic viral hepatitis with related non-alcoholic fatty liver disease

An urgent problem of modern hepatology is the treatment of patients with chronic viral hepatitis C (CHC), which is associated with the prevalence of this disease in the world and the development of serious complications. The presence in these patients of concomitant non-alcoholic fatty liver disease (NAFLD) accelerates the progression rate of HCV infection and reduces the effectiveness of antiviral therapy (AVT). The purpose of the work is to evaluate the effectiveness of the use of a new treatment complex: conducting an AVT and dry carbon dioxide bath (DCDB) procedures in patients with chronic hepatitis C with concomitant NAFLD. Patients of the 1st group received the basic complex of treatment: diet therapy, dosed exercise regimen, AVT included sofosbuvir (400 mg), and ledipasvir (90 mg). Patients of 2 groups on the background of a similar basic therapy additionally received DCDB procedures - 3 series of procedures (10 procedures daily with a break of 20 days). Positive dynamics were established in both groups, but in patients of the 2nd group, it was possible to achieve faster elimination of asthenic and pain abdominal syndromes (p <0.05) and normalize all indicators of the lipid profile (p <0.001).